Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biosyent Inc BIOYF


Primary Symbol: V.RX

Healthcare
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more

Bullboard (TSXV:RX)

View:
Prev 1 2 3 4 5 6 7 8 9 10 Next
Post by Possibleidiot01on Feb 01, 2024 7:34pm

Small Cap Discoveries

https://www.youtube.com/watch?v=ej_ZbQXdRx0
201
Discussion
Post by Possibleidiot01on Oct 18, 2023 7:28pm

Rivemont MicroCap Cocktail Event (September 2023)

https://www.youtube.com/watch?v=9AHlGi9e2RM
200
Post by Daudau11on Sep 19, 2023 8:36am

New Planet Microcap Presentation

BioSyent (TSX-V: RX): Specialty Pharmaceutical Company Focused on Commercializing Assets in Canada - YouTube
243
Post by lscfaon Jul 07, 2023 9:07am

BioSyent Pharma to Introduce Gelclair®

https://www.globenewswire.com/news-release/2023/07/06/2700870/0/en/BioSyent-Pharma-to-Introduce-Gelclair-at-AHNS-11th-International-Conference-on-Head-and-Neck-Cancer.html
158
Post by Betteryear2on Jun 20, 2023 8:00pm

BioSyent Long-term Extension of Cathejell® Agreement

MISSISSAUGA, Ontario, June 20, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc ...more  
213
Post by lscfaon Apr 18, 2023 3:34pm

Presenting at Bloom Burton Conf.

April 25   https://www.bloomburton.com/conference/  
179
Post by lscfaon Mar 07, 2023 6:37pm

Launch of New FeraMAX® Pd Maintenance 45

https://stockhouse.com/news/press-releases/2023/03/07/biosyent-announces-launch-of-new-xa0-feramax-xae-pd-maintenance-45
159
Comment by lscfaon Feb 08, 2023 7:03pm

RE:Jason Del Vicario- BNN - HOLD

Advil now sells an Advil + Acetaminophen product. It is 125mg/250mg Vs Combogesic 97.5mg/375mg. Is the different mix as effective? Is it to avoid infringing Combogesic? costs less too. https ...more  
256
Discussion
Post by Possibleidiot01on Feb 08, 2023 2:42pm

Jason Del Vicario- BNN - HOLD

HOLD BioSyent Inc(RX-X) 08/02/2023     3% conviction level for him. Founder run and owned. 70-80% of its business is from an iron supplement, that ...more  
684
Discussion
Post by lscfaon Dec 14, 2022 10:37pm

Exclusive Agreement for Oncology Supportive Care Product

MISSISSAUGA, Ontario, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an ...more  
226
Post by Possibleidiot01on Dec 14, 2022 6:49am

NCIB

Note the time period for the purchases - long term commitment to strategy. BioSyent has repurchased and cancelled a total of 2,200,625 Shares under NCIBs between December 10, 2018 and December 12 ...more  
299
Post by juanonaon Nov 16, 2022 10:30pm

Building for the future

In the presentation Ren stated they are making investments in people, processes and structure to support a $40-50M + business and get ready for the next accentuated growth phase. Their capital-light ...more  
417
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities